NCT00329173View on ClinicalTrials.gov

PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

August 31, 2004

Conditions
Hypercholesterolaemia
Interventions
DRUG

Rosuvastatin

DRUG

Atorvastatin

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY